Samabriva Biomanufacturing SA
Dissolution volontaire – liquidation 1.5 FTESamabriva Biomanufacturing reported total assets of €1.08m at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jun 2026), with 1.5 full-time equivalent.
The score of Samabriva Biomanufacturing shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Samabriva Biomanufacturing's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 26 May 2025
Samabriva Biomanufacturing's financial analysis
- Solvency-86.3%sector median: 44.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Samabriva Biomanufacturing
Samabriva Biomanufacturing's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.863.501
- VAT number
- BE1002863501
- Peppol
- Registered · 0208:1002863501 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Nov 2023
- Registered office
- 4031 Liège
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Samabriva Biomanufacturing (SA) has been based in Liège since 2023, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 721,999 € and equity of −933,529 €; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -86.3%, below the median of its sector (44.7%).
Companies similar to Samabriva Biomanufacturing
Companies in the same business, of comparable size and area, outside its group.
- Motion Medical Holding Manufacture of medical and dental instruments and supplies Les Bons Villers · balance sheet €4.44m
- Contipharma Wholesale of pharmaceutical and medical goods Seraing · balance sheet €7.21m
- RNA Pioneering Business and other management consultancy activities Ghent · balance sheet €5.63m
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
- Pharmentum Manufacture of pharmaceutical preparations Kontich · balance sheet €1.94m
- Electro-Cap Center Wholesale of pharmaceutical and medical goods Kapellen · balance sheet 909,917 €
- Z-Projects Wholesale of pharmaceutical and medical goods Zandhoven · balance sheet €1.31m
- MFI Wholesale of pharmaceutical and medical goods Ouffet · balance sheet €1.03m
Frequently asked questions about Samabriva Biomanufacturing
What is the revenue of Samabriva Biomanufacturing?
Samabriva Biomanufacturing files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Samabriva Biomanufacturing?
In Belgium, the VAT number is the company number prefixed with BE: BE1002863501 for Samabriva Biomanufacturing, if the company is VAT-registered. Its company number (CBE) is 1002.863.501.
Where is the registered office of Samabriva Biomanufacturing?
According to the CBE register, the registered office of Samabriva Biomanufacturing is in 4031 Liège.
What is the equity of Samabriva Biomanufacturing?
At the close of the 2025 financial year, the equity of Samabriva Biomanufacturing amounts to -933,529 €, a solvency of -86.3% of total assets.
How many people work at Samabriva Biomanufacturing?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Samabriva Biomanufacturing?
The register lists 1 active mandates at Samabriva Biomanufacturing. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Samabriva Biomanufacturing
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →